Ensysce Biosciences (ENSCW) Current Leases (2020 - 2023)
Ensysce Biosciences (ENSCW) reported Current Leases of $2732.0 for Q3 2023, down 92.28% year-over-year from $35403.0 in Q3 2022, and down 75.0% quarter-over-quarter from $10926.0 in Q2 2023.
Ensysce Biosciences (ENSCW) Current Leases (2020 - 2023) Analysis & Trends
Ensysce Biosciences (ENSCW) has 4 years of Current Leases data on file, last reported at $2732.0 in Q3 2023.
- Current Leases for Q3 2023 came in at $2732.0, down 92.28% year-over-year; the trailing twelve-month figure through Sep 2023 was $2732.0 (down 92.28% YoY), and the FY2022 annual result was $27315.0, up 9.81% from the prior year.
- Current Leases declined to $2732.0 in Q3 2023 per ENSCW's latest filing, from $10926.0 in the prior quarter.
- Over five years, Current Leases peaked at $35403.0 in Q3 2022 and troughed at $2732.0 in Q3 2023.
- A 4-year average of $19615.1 and a median of $19120.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases gained 11.8% in 2022, then plunged 92.28% in 2023.
- A 4-year view of Current Leases shows it stood at $25500.0 in 2020, then declined by 2.45% to $24874.0 in 2021, then increased by 9.81% to $27315.0 in 2022, then sank by 90.0% to $2732.0 in 2023.
- Business Quant data shows ENSCW's Current Leases at $2732.0 in Q3 2023, $10926.0 in Q2 2023, and $19120.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 2,732.00 |
| Jun 30, 2023 | 10,926.00 |
| Mar 31, 2023 | 19,120.00 |
| Dec 31, 2022 | 27,315.00 |
| Sep 30, 2022 | 35,403.00 |
| Jun 30, 2022 | 10,313.00 |
| Mar 31, 2022 | 17,716.00 |
| Dec 31, 2021 | 24,874.00 |
| Sep 30, 2021 | 31,667.00 |
| Jun 30, 2021 | 10,200.00 |
| Dec 31, 2020 | 25,500.00 |